Divergent effects of topical deferoxamine treatment on skin and cancer cells uncovers its potential as a safe radioprotective agent in oncological applications. [PDF]
Cancer Cell IntLedwon JK +9 more
europepmc +1 more source
Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan. [PDF]
Sci RepShah AWA +5 more
europepmc +1 more source
Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine [PDF]
, 2016 Mohamed Abdel Malik Hassan +1 more
openalex +1 more source
Exploring the Potential Role of Manganese-Based Zeolitic Imidazolate Framework Nanoparticles in Cancer Therapy: <i>In vitro</i> Studies Using Lung Cancer Cells. [PDF]
Int J NanomedicineIvasiv V +12 more
europepmc +1 more source
In vitro and in vivo effects of deferoxamine in neonatal acute leukemia [PDF]
, 1987 Z Estrov +7 more
openalex +1 more source
1655 IRON BALANCE IN A DEFEROXAMINE (D) TREATED HEMODIALYSIS PATIENT [PDF]
, 1985 Jerold Woodhead +2 more
openalex +1 more source
Development and Design of a Pediatric Case-Based Virtual Escape Room on Acute Iron Toxicity. [PDF]
J Educ Teach Emerg MedBoggs K, Madhok M, Ahluwalia T.
europepmc +1 more source
Combination‐therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron‐loading in aceruloplasminaemia [PDF]
, 2015 Mohsin Badat, Banu Kaya, Paul Telfer
openalex +1 more source
Reduced number of endothelial progenitor cells in adult patients with beta thalassemia major. [PDF]
Ann HematolGoldberg I +9 more
europepmc +1 more source